Hongfeng Wu

600 total citations
18 papers, 503 citations indexed

About

Hongfeng Wu is a scholar working on Biomedical Engineering, Molecular Biology and Biomaterials. According to data from OpenAlex, Hongfeng Wu has authored 18 papers receiving a total of 503 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Biomedical Engineering, 6 papers in Molecular Biology and 5 papers in Biomaterials. Recurrent topics in Hongfeng Wu's work include Nanoplatforms for cancer theranostics (6 papers), Bone Tissue Engineering Materials (5 papers) and Immune cells in cancer (5 papers). Hongfeng Wu is often cited by papers focused on Nanoplatforms for cancer theranostics (6 papers), Bone Tissue Engineering Materials (5 papers) and Immune cells in cancer (5 papers). Hongfeng Wu collaborates with scholars based in China and United Kingdom. Hongfeng Wu's co-authors include Xiangdong Zhu, Xingdong Zhang, Xiao Yang, Xiangfeng Li, Yong Zhou, Zhongtao Li, Jiaoqing Tang, Cong Xiao, Kun Zhang and Wanlu Zhao and has published in prestigious journals such as Science Advances, Frontiers in Microbiology and Acta Biomaterialia.

In The Last Decade

Hongfeng Wu

18 papers receiving 497 citations

Peers

Hongfeng Wu
Jijia Pan China
Xing Lei China
Yu Long China
Yufan Zhu China
Jijia Pan China
Hongfeng Wu
Citations per year, relative to Hongfeng Wu Hongfeng Wu (= 1×) peers Jijia Pan

Countries citing papers authored by Hongfeng Wu

Since Specialization
Citations

This map shows the geographic impact of Hongfeng Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongfeng Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongfeng Wu more than expected).

Fields of papers citing papers by Hongfeng Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hongfeng Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongfeng Wu. The network helps show where Hongfeng Wu may publish in the future.

Co-authorship network of co-authors of Hongfeng Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Hongfeng Wu. A scholar is included among the top collaborators of Hongfeng Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hongfeng Wu. Hongfeng Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Chen, Zhu, Hongfeng Wu, Yan Jin, et al.. (2024). Enhancing melanoma therapy by modulating the immunosuppressive microenvironment with an MMP-2 sensitive and nHA/GNE co-encapsulated hydrogel. Acta Biomaterialia. 188. 79–92. 10 indexed citations
2.
Wang, Yifu, Hongfeng Wu, Chen Zhu, et al.. (2024). Nano-hydroxyapatite promotes cell apoptosis by co-activating endoplasmic reticulum stress and mitochondria damage to inhibit glioma growth. Regenerative Biomaterials. 11. rbae038–rbae038. 4 indexed citations
3.
Wang, Ruiqi, Hongfeng Wu, Xuening Chen, et al.. (2023). Hydroxyapatite nanoparticles promote TLR4 agonist-mediated anti-tumor immunity through synergically enhanced macrophage polarization. Acta Biomaterialia. 164. 626–640. 21 indexed citations
4.
Wu, Hongfeng, Ruiqi Wang, Shu Li, et al.. (2023). Aspect ratio-dependent dual-regulation of the tumor immune microenvironment against osteosarcoma by hydroxyapatite nanoparticles. Acta Biomaterialia. 170. 427–441. 13 indexed citations
5.
Chen, Jialing, Hao Deng, Hongfeng Wu, et al.. (2022). Preclinical efficacy and involvement of mTOR signaling in the mechanism of Orf virus against nasopharyngeal carcinoma cells. Life Sciences. 291. 120297–120297. 6 indexed citations
6.
Chen, Zhu, Jun Cao, Hongfeng Wu, et al.. (2022). Nano-hydroxyapatite-evoked immune response synchronized with controllable immune adjuvant release for strengthening melanoma-specific growth inhibition. Acta Biomaterialia. 145. 159–171. 26 indexed citations
7.
Zeng, Qin, Ruiqi Wang, Hongfeng Wu, et al.. (2022). Hydroxyapatite nanoparticles drive the potency of Toll-like receptor 9 agonist for amplified innate and adaptive immune response. Nano Research. 15(10). 9286–9297. 10 indexed citations
8.
Wu, Hongfeng, Shuo Liu, Siyu Chen, et al.. (2022). A Selective Reduction of Osteosarcoma by Mitochondrial Apoptosis Using Hydroxyapatite Nanoparticles. International Journal of Nanomedicine. Volume 17. 3691–3710. 15 indexed citations
9.
Deng, Hao, Bin Xiao, Jialing Chen, et al.. (2022). The Combined Use of Orf Virus and PAK4 Inhibitor Exerts Anti-tumor Effect in Breast Cancer. Frontiers in Microbiology. 13. 845259–845259. 7 indexed citations
10.
Wu, Jinjie, Cong Feng, Menglu Wang, et al.. (2022). Whisker of biphasic calcium phosphate ceramics: Osteo-immunomodulatory behaviors. Nano Research. 15(10). 9169–9182. 18 indexed citations
11.
Wu, Hongfeng, Jinjie Wu, Qin Zeng, et al.. (2022). The morphology of hydroxyapatite nanoparticles regulates clathrin-mediated endocytosis in melanoma cells and resultant anti-tumor efficiency. Nano Research. 15(7). 6256–6265. 15 indexed citations
12.
Wu, Jinjie, Hongfeng Wu, Cheng Su, et al.. (2021). Exposure to hydroxyapatite nanoparticles enhances Toll-like receptor 4 signal transduction and overcomes endotoxin tolerance in vitro and in vivo. Acta Biomaterialia. 135. 650–662. 20 indexed citations
13.
Zhu, Cheng, Ziteng Liu, Hongwei Chen, et al.. (2021). The Morphology of Hydroxyapatite Nanoparticles Regulates Cargo Recognition in Clathrin-Mediated Endocytosis. Frontiers in Molecular Biosciences. 8. 627015–627015. 21 indexed citations
14.
Zhang, Yuxiang, Hongfeng Wu, Bo Yuan, et al.. (2021). Enhanced osteogenic activity and antibacterial performance in vitro of polyetheretherketone by plasma-induced graft polymerization of acrylic acid and incorporation of zinc ions. Journal of Materials Chemistry B. 9(36). 7506–7515. 21 indexed citations
15.
Li, Zhongtao, Jiaoqing Tang, Hongfeng Wu, et al.. (2020). A systematic assessment of hydroxyapatite nanoparticles used in the treatment of melanoma. Nano Research. 13(8). 2106–2117. 22 indexed citations
16.
Wu, Hongfeng, Zhongtao Li, Jiaoqing Tang, et al.. (2019). <p>The in vitro and in vivo anti-melanoma effects of hydroxyapatite nanoparticles: influences of material factors</p>. International Journal of Nanomedicine. Volume 14. 1177–1191. 37 indexed citations
17.
Zhang, Kun, Yong Zhou, Cong Xiao, et al.. (2019). Application of hydroxyapatite nanoparticles in tumor-associated bone segmental defect. Science Advances. 5(8). eaax6946–eaax6946. 230 indexed citations
18.
Liu, Dan, Yonghao Wu, Hongfeng Wu, et al.. (2018). Effect of process parameters on the microstructure and property of hydroxyapatite precursor powders and resultant sintered bodies. International Journal of Applied Ceramic Technology. 16(2). 444–454. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026